Drug Trial Radar · NCT07548632
A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
160
Planned (sponsor's estimate)
Start
Apr 16, 2026
Primary completion
Dec 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- OculisIndustry
- Sponsor type
- Industry
- First posted
- Apr 23, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of licaminlimab as compared to vehicle in participants with Dry Eye Disease and a specific genotype.
Conditions
- Dry Eye Disease (DED)
Interventions
Artificial Tear Run-inOther
Artificial tear eye drop run-in three times daily (TID) for approximately 14 days.
licaminlimabDrug
Licaminlimab eye drops three times daily (TID) for 29 days.
Vehicle of licaminlimabOther
Inert ophthalmic solution vehicle of licaminlimab, three times daily (TID) for 29 days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in global ocular discomfort severity score at Day 29 in participants with DED and specific TNFR1 genotypeTime frame: From Day 1 to Day 29
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
East West Eye Institute
Aliso Viejo, California
Orange County Ophthalmology
Garden Grove, California
Global Research Management
Glendale, California
LoBue Laser and Eye Medical Center
Murrieta, California
Eye Research Foundation
Newport Beach, California
North Bay Eye Associates, Inc.
Petaluma, California
Vision Institute
Colorado Springs, Colorado
Segal Drug Trials, Inc.
Delray Beach, Florida
Oculus Research, Inc.
Garner, North Carolina
CORE, Inc
Shelby, North Carolina
Scott & Christie and Associates
Cranberry Township, Pennsylvania
Erie Retina Research
Erie, Pennsylvania
Total Eye Care, PA
Memphis, Tennessee
Piedmont Eye Center, Inc.
Lynchburg, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.